French drug major Sanofi and the US unit of Israel’s Teva Pharmaceutical Industries have presented new, detailed results from the RELIEVE UCCD Phase IIb study of duvakitug, a human IgG1-λ2 monoclonal ...
REYKJAVIK, Iceland and PARSIPPANY, NJ, USA I1, 2025 I Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: ...
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s diseaseNew detailed data from the RELIEVE UCCD ...
Shares of Teva Pharma marginally down 1% in early morning trading, while Alvotech's saw a 5% increase. Alvotech is in charge of development and manufacturing of Selarsdi, while Teva holds the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback